LS ARK Genomic Revolution Tracker ETP Securities XS2399368062
3.43
EUR
0.12
EUR
3.54 %
21.08.2026
NAV
| Kurse | Charts | Stammdaten | Kennzahlen | Aktion |
|---|---|---|---|---|
| Snapshot | Preischart | Daten + Gebühr | Performance | Portfolio |
| Börsenplätze | Performance | Management | Volatilität | Watchlist |
| Historisch | Benchmark | Sharpe Ratio | ||
| Rendite | Ratings |
Kurse
Charts
Stammdaten
Kennzahlen
Nettoinventarwert (NAV)
| 3.88 USD | -0.01 USD | -0.19 % |
|---|
| Vortag | 3.89 USD | Datum | 20.08.2026 |
LS ARK Genomic Revolution Tracker ETP Securities Kurs - 1 Jahr
Anzeige
Top Kryptowährungen ETPs
| Name | ISIN | Performance | |
|---|---|---|---|
| 21shares Hyperliquid Staking ETP | CH1471826029 | 40.17% | |
| 21Shares Stellar ETP | CH1109575535 | 24.61% | |
| 21shares Morpho ETP | CH1506167027 | 18.96% | |
| 21Shares Chainlink ETP | CH1100083471 | 8.81% | |
| 21Shares Aave ETP | CH1135202120 | 8.28% | |
| 21shares Jito Staked SOL ETP USD | CH1521714696 | 2.83% | |
| 21shares Strategy Yield ETP USD | CH1528107811 | -1.12% | |
| 21Shares Injective Staking ETP | CH1360612134 | -9.07% | |
| 21Shares Jupiter ETP | CH1480821383 | -12.75% | |
| 21Shares Maple Finance ETP | CH1495416989 | -17.43% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21shares Hyperliquid Staking ETP | CH1471826029 | 138.92% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 64.50% | |
| 21shares Morpho ETP | CH1506167027 | 39.52% | |
| 21Shares Injective Staking ETP | CH1360612134 | 34.93% | |
| 21Shares Ondo ETP | CH1396389921 | 28.80% | |
| 21Shares Pendle ETP | CH1495416997 | 18.30% | |
| 21Shares Chainlink ETP | CH1100083471 | 18.01% | |
| 21Shares Jupiter ETP | CH1480821383 | 16.85% | |
| 21Shares Bittensor ETP | CH1495416971 | 12.81% | |
| 21shares Jito Staked SOL ETP USD | CH1521714696 | 4.87% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Bitcoin Gold ETP | CH1146882308 | 7.80% | |
| 21Shares Binance BNB ETP | CH0496454155 | -24.48% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | -30.78% | |
| 21Shares Bitcoin Core ETP | CH1199067674 | -36.96% | |
| 21Shares Bitcoin ETP | CH0454664001 | -37.83% | |
| 21Shares Cronos Staking ETP | CH1443364232 | -62.10% | |
| 21Shares Dogecoin ETP | CH1431521033 | -64.28% | |
| 21Shares Injective Staking ETP | CH1360612134 | -66.03% | |
| 21Shares XDC Network ETP | CH1464217285 | -67.02% | |
| 21Shares Sui Staking ETP | CH1360612159 | -79.32% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares XRP ETP | CH0454664043 | 96.00% | |
| 21Shares Stellar ETP | CH1109575535 | 76.39% | |
| 21Shares Bitcoin Gold ETP | CH1146882308 | 58.33% | |
| 21Shares Crypto Basket Equal Weight (HODLV) ETP | CH1135202161 | 39.76% | |
| 21Shares Bitcoin Core ETP | CH1199067674 | 20.02% | |
| 21Shares Sui Staking ETP | CH1360612159 | -18.99% | |
| 21Shares Injective Staking ETP | CH1360612134 | -75.52% |
Fundamentaldaten
| Valor | |
| ISIN | XS2399368062 |
| Emittent | Leverage Shares PLC |
| Aufgelegt in | Ireland |
| Auflagedatum | 10.12.2021 |
| Kategorie | Branchen: Biotechnologie |
| Währung | USD |
| Volumen | 837’531.20 |
| Depotbank | |
| Geschäftsjahresende | |
| Berichtsstand | 21.08.2026 |
Anlagepolitik
So investiert der LS ARK Genomic Revolution Tracker ETP Securities: The objective of the ETP is to track the ARKG Genomic Tracker Investment Strategy, (the 'Investment Strategy') which is designed to provide 1:1 exposure to the performance of ARK Genomic Revolution ETF (the “Reference Asset”), minus a fee. It invests all subscription proceeds and dividends received (net of taxes) directy into Reference Assets.
ETP Performance: LS ARK Genomic Revolution Tracker ETP Securities
| Performance 1 Jahr | 97.65 | |
| Performance 2 Jahre | 80.09 | |
| Performance 3 Jahre | 55.31 | |
| Performance 5 Jahre | - | |
| Performance 10 Jahre | - |
ETP Kategorievergleich
| Name | 1J Perf. | |
|---|---|---|
| ARK Genomic Revolution UCITS ETF Class A USD Accumulation | 98.29 |